Abstract

IntroductionEvidence behind the recommendations for protein feeding during critical illness is weak. Mechanistic studies are needed to elucidate the effects of amino acid and/or protein supplementation on protein metabolism before larger clinical trials with higher levels of protein feeding are initiated.MethodsWe studied the effects of parenteral amino acid supplementation (equivalent to 1 g/kg/day) over the course of 3 hours on whole-body protein turnover in critically ill patients in the intensive care unit (ICU) during the first week after admission. Patients were studied at baseline during ongoing nutrition and during extra amino acid supplementation. If the patient was still in the ICU 2 to 4 days later, these measurements were repeated. Protein kinetics were measured using continuous stable isotope-labeled phenylalanine and tyrosine infusions.ResultsThirteen patients were studied on the first study occasion only, and seven were studied twice. Parenteral amino acid supplementation significantly improved protein balance on both occasions, from a median of −4 to +7 μmol phenylalanine/kg/hr (P =0.001) on the first study day and from a median of 0 to +12 μmol phenylalanine/kg/hr (P =0.018) on the second study day. The more positive protein balance was attributed to an increased protein synthesis rate, which reached statistical significance during the first measurement (from 58 to 65 μmol phenylalanine/kg/hr; n =13; P =0.007), but not during the second measurement (from 58 to 69 μmol phenylalanine/kg/hr; n =7; P =0.09). Amino acid oxidation rates, estimated by phenylalanine hydroxylation, did not increase during the 3-hour amino acid infusion. A positive correlation (r =0.80; P <0.0001) was observed between total amino acids and/or protein given to the patient and whole-body protein balance.ConclusionExtra parenteral amino acids infused over a 3-hour period improved whole-body protein balance and did not increase amino acid oxidation rates in critically ill patients during the early phase (first week) of critical illness.Electronic supplementary materialThe online version of this article (doi:10.1186/s13054-015-0844-6) contains supplementary material, which is available to authorized users.

Highlights

  • Evidence behind the recommendations for protein feeding during critical illness is weak

  • We investigated the effect of an increased parenteral amino acid supply on top of ongoing nutrition in critically ill patients during the first week of intensive care unit (ICU) treatment

  • The three cohorts were comparable with regard to age, sex, weight, diagnosis, Simplified Acute Physiology Score III and Sequential Organ Failure Assessment score

Read more

Summary

Introduction

Evidence behind the recommendations for protein feeding during critical illness is weak. Mechanistic studies are needed to elucidate the effects of amino acid and/or protein supplementation on protein metabolism before larger clinical trials with higher levels of protein feeding are initiated. Ill patients are characterized by a progressive loss of lean body mass, mainly confined to skeletal muscle mass. The loss of this lean body mass is related to a worsened outcome. The effects of varying caloric and protein supply have been addressed in clinical studies, the evidence underlying clinical recommendations for protein feeding in critically ill patients remains weak, as reviewed by Hoffer and Bistrian [1]. Subsequently larger, clinical trials are needed to solve this problem

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call